Depression and the Blood Systems That Shape Mood
Depression biomarkers are measurable signals in blood that mirror the brain–body systems shaping mood, motivation, and energy. They capture how the stress response is operating (hypothalamic–pituitary–adrenal, HPA axis), whether the immune system is activated (systemic inflammation, cytokines), how well nerve cells support growth and connectivity (neurotrophic factors such as BDNF), and how the body manages fuel and timing (metabolic and circadian regulation). Blood testing turns these hidden processes into an objective snapshot that complements conversation and symptom scales. It can reveal when biology is pushing mood through specific pathways, help distinguish different biological “flavors” of depression, and provide a baseline to track change as treatment proceeds. By showing which levers are most perturbed for a given person—stress signaling, immune activity, neuroplasticity, or metabolism—biomarkers enable more targeted choices and clearer monitoring of recovery. In short, they translate an internal experience into a measurable profile (biological phenotype) that can inform care while working alongside clinical judgment and personal goals.
Why a Biological Read Helps Frame the Clinical Picture
Depression is not just a brain state; it’s a whole-body condition shaped by stress hormones, inflammation, and immune balance. Blood biomarkers help map these systems: cortisol reflects the brain–adrenal stress axis, high-sensitivity CRP (hs-CRP) captures systemic inflammatory tone, and the neutrophil-to-lymphocyte ratio (NLR) shows the balance between innate and adaptive immunity. Together, they clarify whether mood symptoms ride on stress reactivity, inflammation, or immune dysregulation.Typical morning cortisol lands around 10–20, with an optimal pattern in the mid-range and a clear drop by evening. When high, people often feel wired-tired, anxious, and sleep-fragmented; when low or flattened, energy, motivation, and stress tolerance sag. hs-CRP under 1 is generally favorable, 1–3 is average, and over 3 suggests heightened inflammation; lower values tend to be optimal. NLR usually sits near 1–3; the lower end of normal often reflects a calm immune set point, while higher values track physiological stress. Women often show slightly higher hs-CRP than men, and pregnancy raises cortisol and hs-CRP as normal adaptations; children typically have lower NLR.When these markers run low, they tell different stories. Low morning cortisol or a blunted rhythm points to underactive HPA signaling (hypocortisolism), seen in some depression subtypes, with fatigue, hypersomnia, pain sensitivity, and cognitive slowing; teens and the postpartum period may feel this as overwhelming tiredness and reduced stress resilience. Very low hs-CRP usually means minimal systemic inflammation; in depression, it suggests symptoms are driven more by neural circuitry or psychosocial load than inflammation. A markedly low NLR—often from neutropenia or relative lymphocytosis—can indicate viral illness, autoimmune activity, or medication effects, showing up as frequent infections or mouth ulcers; mood effects are typically indirect.Big picture, these markers connect mood to endocrine, immune, metabolic, and sleep systems. Persistent inflammation or stress-axis disruption links to cardiometabolic risk, pain amplification, and cognitive change over time. Tracking cortisol, hs-CRP, and NLR alongside thyroid, glucose–insulin, lipids, vitamin D/B12, and sex steroids provides a systems view of depression biology and its long-term health implications.
What These Markers Can and Can't Tell You About Depression
Depression blood testing offers a window into how your body’s stress, immune, and inflammatory systems are functioning—key players in energy, metabolism, cardiovascular health, cognition, and even immunity. At Superpower, we focus on three biomarkers: Cortisol, high-sensitivity C-reactive protein (hs-CRP), and the neutrophil-to-lymphocyte ratio (NLR). Together, these markers help reveal the biological patterns that often accompany depression.Cortisol is a hormone released in response to stress, regulating energy, metabolism, and the body’s daily rhythms. In depression, cortisol levels can be higher or more erratic, reflecting chronic stress or disrupted circadian patterns. hs-CRP is a sensitive marker of inflammation; elevated levels suggest the immune system is more active than usual, which is commonly seen in depression and linked to changes in mood and cognition. NLR measures the balance between two types of white blood cells—neutrophils and lymphocytes—offering insight into immune system activity and inflammation, both of which can shift in depressive states.Healthy stability in these biomarkers supports emotional resilience and balanced brain chemistry. When cortisol, hs-CRP, or NLR are outside typical ranges, it may signal that the body’s stress and immune responses are under strain, which can contribute to or reflect depressive symptoms.Interpretation of these results depends on context. Factors like age, pregnancy, acute illness, chronic conditions, medications, and even lab methods can influence levels. Understanding your unique situation is essential for accurate assessment.
FAQs
Depression blood testing does not diagnose depression. It profiles body systems that shape mood and energy. Superpower measures cortisol (HPA-axis stress hormone), high-sensitivity CRP (systemic inflammation), and the neutrophil-to-lymphocyte ratio, NLR (innate–adaptive immune balance). These markers help reveal stress physiology, inflammatory tone, and immune activation that can amplify depressive symptoms or mimic them, and they can uncover medical contributors that deserve attention.
To map biology behind symptoms. Cortisol shows HPA-axis load and circadian stress patterns. hs-CRP reflects silent systemic inflammation. NLR indicates immune shift toward stress and inflammation. Together, these data help rule out contributors, establish a baseline, and track change over time alongside clinical care. They inform, not label—useful for precision monitoring, not for diagnosing depression by themselves.
Yes. With Superpower, our team can organize a professional blood draw in your home and coordinate the lab processing for cortisol, hs-CRP, and NLR.
Start with a baseline. If symptoms change or treatment starts, recheck in about 8–12 weeks to see directionality. Once stable, periodic monitoring (for example, every 6–12 months) is reasonable. More frequent testing may be useful during acute illness or high stress, since these markers are dynamic.
Acute infection, injury, fever, strenuous exercise, poor sleep, psychological stress, menstrual phase, and dehydration can all shift cortisol, hs-CRP, and NLR. Medications—especially corticosteroids, anti-inflammatories, and immune-modulating drugs—also move these markers. Smoking and heavy alcohol use can raise inflammatory signals. Always interpret results in the context of recent health events and medications.
Prefer a morning draw (about 7–9 a.m.) for cortisol, since it follows a daily rhythm. Rest quietly for 10–15 minutes before the draw. Avoid vigorous exercise and acute illness beforehand if possible. Fasting is not required for hs-CRP or NLR. If you take steroids or other immune-active drugs, note the timing of your last dose for accurate interpretation.
References
- Stetler, C., & Miller, G. E. (2011). Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Medicine, 73(2), 114-126. https://doi.org/10.1097/PSY.0b013e31820ad12b
- Howren, M. B., Lamkin, D. M., & Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71(2), 171-186. https://doi.org/10.1097/PSY.0b013e3181907c1b
- Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22-34. https://doi.org/10.1038/nri.2015.5
- Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018). Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 84(Pt A), 229-236. https://doi.org/10.1016/j.pnpbp.2018.03.012
- Kishi, T., Yoshimura, R., Ikuta, T., & Iwata, N. (2018). Brain-derived neurotrophic factor and major depressive disorder: Evidence from meta-analyses. Frontiers in Psychiatry, 8, 308. https://doi.org/10.3389/fpsyt.2017.00308






































.avif)
